These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 10923465

  • 1. [The effect of expressed human apolipoprotein AI on plasma high density lipoprotein level in transgenic mice].
    Li H, Gu S, She M.
    Zhonghua Yi Xue Za Zhi; 1998 Jul; 78(7):531-3. PubMed ID: 10923465
    [Abstract] [Full Text] [Related]

  • 2. Suppression of induced atherosclerosis in h-apo AI transgenic mice by overexpression of human apo AI in the aortic wall.
    Li H, Gu S, Cao X, Wang Z, She M.
    Chin Med J (Engl); 2000 Jul; 113(7):657-61. PubMed ID: 11776042
    [Abstract] [Full Text] [Related]

  • 3. [Effect of oxLDL on the uptake and clearance rate of cholesterol in vascular smooth muscle cells originated from human apoAI transgenic mice].
    Zeng Y, Zhao GF, Qian J, Wang ZL, She MP.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Aug; 23(4):328-32. PubMed ID: 12940070
    [Abstract] [Full Text] [Related]

  • 4. Opposite regulation of human versus mouse apolipoprotein A-I by fibrates in human apolipoprotein A-I transgenic mice.
    Berthou L, Duverger N, Emmanuel F, Langouët S, Auwerx J, Guillouzo A, Fruchart JC, Rubin E, Denèfle P, Staels B, Branellec D.
    J Clin Invest; 1996 Jun 01; 97(11):2408-16. PubMed ID: 8647932
    [Abstract] [Full Text] [Related]

  • 5. Induction of bile acid synthesis by cholesterol and cholestyramine feeding is unimpaired in mice deficient in apolipoprotein AI.
    Jolley CD, Dietschy JM, Turley SD.
    Hepatology; 2000 Dec 01; 32(6):1309-16. PubMed ID: 11093738
    [Abstract] [Full Text] [Related]

  • 6. Effects of hypolipidemic drugs on the expression of genes involved in high density lipoprotein metabolism in the rat.
    Staels B, Van Tol A, Fruchart JC, Auwerx J.
    Isr J Med Sci; 1996 Jun 01; 32(6):490-8. PubMed ID: 8682657
    [Abstract] [Full Text] [Related]

  • 7. Long-term stable expression of human apolipoprotein A-I mediated by helper-dependent adenovirus gene transfer inhibits atherosclerosis progression and remodels atherosclerotic plaques in a mouse model of familial hypercholesterolemia.
    Belalcazar LM, Merched A, Carr B, Oka K, Chen KH, Pastore L, Beaudet A, Chan L.
    Circulation; 2003 Jun 03; 107(21):2726-32. PubMed ID: 12742997
    [Abstract] [Full Text] [Related]

  • 8. Lipoprotein analysis in transgenic mice expressing human apolipoprotein (apo) A-I and apo C III: use of micromethods in analysis of lipoprotein system in mice.
    Ito Y.
    Hokkaido Igaku Zasshi; 1994 Mar 03; 69(2):312-26. PubMed ID: 8157256
    [Abstract] [Full Text] [Related]

  • 9. Protein composition determines the anti-atherogenic properties of HDL in transgenic mice.
    Schultz JR, Verstuyft JG, Gong EL, Nichols AV, Rubin EM.
    Nature; 1993 Oct 21; 365(6448):762-4. PubMed ID: 8413656
    [Abstract] [Full Text] [Related]

  • 10. Substitution of the carboxyl-terminal domain of apo AI with apo AII sequences restores the potential of HDL to reduce the progression of atherosclerosis in apo E knockout mice.
    Holvoet P, Danloy S, Deridder E, Lox M, Bernar H, Dhoest A, Collen D.
    J Clin Invest; 1998 Jul 15; 102(2):379-85. PubMed ID: 9664079
    [Abstract] [Full Text] [Related]

  • 11. G to A substitution in the promoter region of the apolipoprotein AI gene is associated with elevated serum apolipoprotein AI and high density lipoprotein cholesterol concentrations.
    Jeenah M, Kessling A, Miller N, Humphries S.
    Mol Biol Med; 1990 Jun 15; 7(3):233-41. PubMed ID: 1977072
    [Abstract] [Full Text] [Related]

  • 12. Thyroid hormone increases plasma cholesteryl ester transfer protein activity and plasma high-density lipoprotein removal rate in transgenic mice.
    Berti JA, Amaral ME, Boschero AC, Nunes VS, Harada LM, Castilho LN, Oliveira HC.
    Metabolism; 2001 May 15; 50(5):530-6. PubMed ID: 11319713
    [Abstract] [Full Text] [Related]

  • 13. Apolipoprotein AI and apolipoprotein E mRNA expression in peripheral white blood cells from patients with orthotopic liver transplantation.
    Martínez-López E, Nuño-González P, Ruiz-Madrigal B, Rodríguez-Sancho LC, Hernández-Nazará ZH, Segura-Ortega JE, Panduro A.
    Liver Int; 2007 Sep 15; 27(7):930-7. PubMed ID: 17696931
    [Abstract] [Full Text] [Related]

  • 14. [Value of transgenic mouse as model for the study of human lipoprotein metabolism].
    Fournier N, Atger V, Paul JL, Moatti N.
    Ann Biol Clin (Paris); 1995 Sep 15; 53(4):209-20. PubMed ID: 7574108
    [Abstract] [Full Text] [Related]

  • 15. [Hydrodynamics-based transfer of human apolipoprotein A-I gene into mice: study of factors involving an efficacy and duration of the transferred gene expression in animals' liver].
    Ajuf'ev BN, Dizhe EB, Efremov AM, Mogilenko DA, Oleĭnikova GN, Lapikov IA, Zhdanova OIu, Kidgotko OV, Orlov SV, Perevozchikov AP.
    Mol Biol (Mosk); 2004 Sep 15; 38(6):1076-84. PubMed ID: 15612596
    [Abstract] [Full Text] [Related]

  • 16. Hyperexpression of N-acetylglucosaminyltransferase-III in liver tissues of transgenic mice causes fatty body and obesity through severe accumulation of Apo A-I and Apo B.
    Lee J, Song EY, Chung TW, Kang SK, Kim KS, Chung TH, Yeom YI, Kim CH.
    Arch Biochem Biophys; 2004 Jun 01; 426(1):18-31. PubMed ID: 15130779
    [Abstract] [Full Text] [Related]

  • 17. Atheroprotective potential of macrophage-derived phospholipid transfer protein in low-density lipoprotein receptor-deficient mice is overcome by apolipoprotein AI overexpression.
    Valenta DT, Ogier N, Bradshaw G, Black AS, Bonnet DJ, Lagrost L, Curtiss LK, Desrumaux CM.
    Arterioscler Thromb Vasc Biol; 2006 Jul 01; 26(7):1572-8. PubMed ID: 16675720
    [Abstract] [Full Text] [Related]

  • 18. Atherosclerotic lesion formation and triglyceride storage in obese apolipoprotein AI-deficient mice.
    Plummer MR, Hasty AH.
    J Nutr Biochem; 2008 Oct 01; 19(10):664-73. PubMed ID: 18280133
    [Abstract] [Full Text] [Related]

  • 19. An apolipoprotein(a) peptide delays chylomicron remnant clearance and increases plasma remnant lipoproteins and atherosclerosis in vivo.
    Devlin CM, Lee SJ, Kuriakose G, Spencer C, Becker L, Grosskopf I, Ko C, Huang LS, Koschinsky ML, Cooper AD, Tabas I.
    Arterioscler Thromb Vasc Biol; 2005 Aug 01; 25(8):1704-10. PubMed ID: 15905467
    [Abstract] [Full Text] [Related]

  • 20. Different VLDL apo B, and HDL apo AI and apo AII metabolism in two heterozygous carriers of unrelated mutations in the lipoprotein lipase gene.
    Pérez-Méndez O, Duhal N, Lacroix B, Bonte JP, Fruchart JC, Luc G.
    Clin Chim Acta; 2006 Jun 01; 368(1-2):149-54. PubMed ID: 16487502
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.